Closing the loop between computational prediction and experimental validation with cell-free synthetic biology and high-throughput nanofluidics
Location: Switzerland
Employees: 11-50
Total raised: $10.7M
Founded date: 2020
Investors 7
Funding Rounds 2
| Date | Series | Amount | Investors |
| 19.09.2025 | Seed | $8M | ACE Ventur... |
| 14.02.2022 | Pre-Seed | $2.7M | - |
Mentions in press and media 10
| Date | Title | Description |
| 19.09.2025 | Adaptyv leaves the beta phase following its $8m seed round | Epalinges-based Adaptyv Bio is on the mission to accelerate the design process for proteins, which today remains a long, very tedious, and expensive task as labs and companies lack the automation and data integration to perform repeatable,... |
| 17.04.2023 | Adaptyv Bio launches its protein-engineering platform | |
| 14.02.2022 | Adaptyv Biosystems raises USD 2.5 million to create the world’s largest protein design database | Adaptyv Biosystems, which won Venture Kick stage 2 in 2021, is focussing on the development of high-throughput protein synthesis and screening. Using synthetic biology and machine learning, Adaptyv massively scales up the number of protein ... |
| 16.12.2021 | Biopôle Start-up Fund supports Adaptyv Biosystems and Alithea Genomics | Adaptyv Biosystems is a game changer in its area of expertise: high-throughput protein synthesis and screening. By miniaturising its technology thanks to a nanofluidic chip, the start-up has already made its offering 100,000 times smaller t... |
| 15.09.2021 | CHF 40,000 for startups developing the next-generation of antibody engineering, enjoyable prosthetics, and antibodies for the treatment of Leukemia | Adaptyv Biosystems: enabling the next-generation of antibody engineering Antibodies have become the fastest-growing class of therapeutics in recent years. They have great potential for the treatment of several high-impact diseases such as c... |
| 01.09.2021 | Here are all the companies from Day 2 of Y Combinator’s Summer 2021 Demo Day | Welcome back to TechCrunch’s continuing coverage of Y Combinator’s Summer 2021 Demo Day! This is Day Two. If you haven’t caught up yet on what happened during the first day, you can read our recap of all the presenting companies here, our f... |
| 05.08.2021 | Three startups each receive CHF 100,000 Innogrants | The EPFL Tech Launchpad aims to empower entrepreneurs, providing them with the right support to launch the companies of tomorrow. During the incubation program, each selected team receives tailored support including dedicated funding, exter... |
| 04.08.2021 | EPFL spin-off secures funding from Y Combinator | After getting support through EPFL's Ignition grant and FIT Innogrant, Adaptyv Biosystems has received a pre-seed investment from Y Combinator (YC), the world's most selective startup accelerator. The pre-seed round includes CHF 140,000 fro... |
| 28.04.2021 | Startups developing the next-generation of antibody engineering, AI-based automation for the coating industry, enjoyable prosthetics, automated indoor farming solutions, and an on-demand tutoring plat... | Adaptyv Biosystems: enabling the next-generation of antibody engineering Antibodies have become the fastest growing class of therapeutics in recent years. They have great potential for the treatment of several high-impact diseases such as c... |
| - | Adaptyv Biosystems | “Proteins are the most advanced nanotechnology we know of. At Adaptyv Bio we’re building an next-gen protein foundry to allow you to synthesize and test any protein you design.” |